| Year |
Citation |
Score |
| 2024 |
Rodríguez-Mora S, Sánchez-Menéndez C, Bautista-Carrascosa G, Mateos E, Moreno-Serna L, Megías D, Cantón J, García-Gutiérrez V, Murciano-Antón MA, Cervero M, Spivak A, Planelles V, Coiras M. Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV. Biochemical Pharmacology. 229: 116512. PMID 39222713 DOI: 10.1016/j.bcp.2024.116512 |
0.473 |
|
| 2024 |
LaPorte A, Pathak R, Eliscovich C, Martins L, Nell R, Spivak A, Suzuki M, Planelles V, Singer R, Kalpana G. Single-molecule RNA-FISH analysis reveals stochasticity in reactivation of latent HIV-1 regulated by Nuclear Orphan Receptors NR4A and cMYC. Research Square. PMID 38699331 DOI: 10.21203/rs.3.rs-4166090/v1 |
0.512 |
|
| 2022 |
Williams ESCP, Szaniawski MA, Martins LJ, Innis EA, Alcamí J, Hanley TM, Spivak AM, Coiras M, Planelles V. Dasatinib: effects on the macrophage phospho proteome with a focus on SAMHD1 and HIV-1 infection. Clinical Research in Hiv/Aids. 8. PMID 36589263 |
0.435 |
|
| 2022 |
Cruz-Lorenzo E, Ramirez NP, Lee J, Pandhe S, Wang L, Hernandez-Doria J, Spivak AM, Planelles V, Petersen T, Jain MK, Martinez ED, D'Orso I. Host Cell Redox Alterations Promote Latent HIV-1 Reactivation through Atypical Transcription Factor Cooperativity. Viruses. 14. PMID 36298843 DOI: 10.3390/v14102288 |
0.524 |
|
| 2022 |
Dickey LL, Martins LJ, Planelles V, Hanley TM. HIV-1-induced type I IFNs promote viral latency in macrophages. Journal of Leukocyte Biology. PMID 35588262 DOI: 10.1002/JLB.4MA0422-616R |
0.521 |
|
| 2022 |
Ramirez NP, Lee J, Zheng Y, Li L, Dennis B, Chen D, Challa A, Planelles V, Westover KD, Alto NM, D'Orso I. ADAP1 promotes latent HIV-1 reactivation by selectively tuning KRAS-ERK-AP-1 T cell signaling-transcriptional axis. Nature Communications. 13: 1109. PMID 35232997 DOI: 10.1038/s41467-022-28772-0 |
0.466 |
|
| 2022 |
Martins LJ, Szaniawski MA, Williams ESCP, Coiras M, Hanley TM, Planelles V. HIV-1 Accessory Proteins Impart a Modest Interferon Response and Upregulate Cell Cycle-Related Genes in Macrophages. Pathogens (Basel, Switzerland). 11. PMID 35215107 DOI: 10.3390/pathogens11020163 |
0.48 |
|
| 2022 |
Lim AL, Moos P, Pond CD, Larson EC, Martins LJ, Szaniawski MA, Planelles V, Barrows LR. HIV-1 provirus transcription and translation in macrophages differs from pre-integrated cDNA complexes and requires E2F transcriptional programs. Virulence. 13: 386-413. PMID 35166645 DOI: 10.1080/21505594.2022.2031583 |
0.518 |
|
| 2021 |
Larragoite ET, Nell RA, Martins LJ, Barrows LR, Planelles V, Spivak AM. Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulation. Biochemical Pharmacology. 195: 114844. PMID 34801521 DOI: 10.1016/j.bcp.2021.114844 |
0.352 |
|
| 2021 |
Sarabia I, Novis CL, Macedo AB, Takata H, Nell R, Kakazu JC, Furler RL, Shakya B, Schubert HL, Hill CP, DePaula-Silva AB, Spivak AM, Trautmann L, Planelles V, Bosque A. Activation of the Anti-Oxidative Stress Response Reactivates Latent HIV-1 Through the Mitochondrial Antiviral Signaling Protein Isoform MiniMAVS. Frontiers in Immunology. 12: 682182. PMID 34194436 DOI: 10.3389/fimmu.2021.682182 |
0.49 |
|
| 2021 |
Vigón L, Martínez-Román P, Rodríguez-Mora S, Torres M, Puertas MC, Mateos E, Salgado M, Navarro A, Sánchez-Conde M, Ambrosioni J, Cervero M, Wyen C, Hoffmann C, Miró JM, Alcamí J, ... ... Planelles V, et al. Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy. Biochemical Pharmacology. 114666. PMID 34186065 DOI: 10.1016/j.bcp.2021.114666 |
0.503 |
|
| 2021 |
Zheng Y, Schubert HL, Singh PK, Martins LJ, Engelman AN, D'Orso I, Hill CP, Planelles V. Cleavage and Polyadenylation Specificity Factor 6 Is Required for Efficient HIV-1 Latency Reversal. Mbio. e0109821. PMID 34154414 DOI: 10.1128/mBio.01098-21 |
0.528 |
|
| 2021 |
Viglianti GA, Planelles V, Hanley TM. Interactions with Commensal and Pathogenic Bacteria Induce HIV-1 Latency in Macrophages through Altered Transcription Factor Recruitment to the LTR. Journal of Virology. PMID 33472928 DOI: 10.1128/JVI.02141-20 |
0.535 |
|
| 2021 |
Scott TA, O'Meally D, Grepo NA, Soemardy C, Lazar DC, Zheng Y, Weinberg MS, Planelles V, Morris KV. Broadly active zinc finger protein-guided transcriptional activation of HIV-1. Molecular Therapy. Methods & Clinical Development. 20: 18-29. PMID 33335944 DOI: 10.1016/j.omtm.2020.10.018 |
0.58 |
|
| 2020 |
Pache L, Marsden MD, Teriete P, Portillo AJ, Heimann D, Kim JT, Soliman MSA, Dimapasoc M, Carmona C, Celeridad M, Spivak AM, Planelles V, Cosford NDP, Zack JA, Chanda SK. Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs . Cell Reports. Medicine. 1: 100037. PMID 33205060 DOI: 10.1016/j.xcrm.2020.100037 |
0.516 |
|
| 2020 |
Schynkel T, Szaniawski MA, Spivak AM, Bosque A, Planelles V, Vandekerckhove L, Trypsteen W. Interferon-Mediated Long Non-Coding RNA Response in Macrophages in the Context of HIV. International Journal of Molecular Sciences. 21. PMID 33086748 DOI: 10.3390/ijms21207741 |
0.408 |
|
| 2020 |
Abdel-Mohsen M, Richman D, Siliciano RF, Nussenzweig MC, Howell BJ, Martinez-Picado J, Chomont N, Bar KJ, Yu XG, Lichterfeld M, Alcami J, Hazuda D, Bushman F, Siliciano JD, Betts MR, ... ... Planelles V, et al. Recommendations for measuring HIV reservoir size in cure-directed clinical trials. Nature Medicine. PMID 32895573 DOI: 10.1038/S41591-020-1022-1 |
0.573 |
|
| 2020 |
Vigón L, Rodríguez-Mora S, Luna A, Sandonís V, Mateos E, Bautista G, Steegmann JL, Climent N, Plana M, Pérez-Romero P, de Ory F, Alcamí J, García-Gutierrez V, Planelles V, López-Huertas MR, et al. Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection. Biochemical Pharmacology. 182: 114203. PMID 32828803 DOI: 10.1016/J.Bcp.2020.114203 |
0.589 |
|
| 2020 |
Sorensen ES, Macedo AB, Resop RS, Howard JN, Nell R, Sarabia I, Newman D, Ren Y, Jones RB, Planelles V, Spivak AM, Bosque A. Structure activity relationship analysis of benzotriazine analogues as HIV-1 Latency Reversing Agents. Antimicrobial Agents and Chemotherapy. PMID 32482680 DOI: 10.1128/Aac.00888-20 |
0.562 |
|
| 2020 |
Byun S, Han S, Zheng Y, Planelles V, Lee Y. The landscape of alternative splicing in HIV-1 infected CD4 T-cells. Bmc Medical Genomics. 13: 38. PMID 32241262 DOI: 10.1186/S12920-020-0680-7 |
0.567 |
|
| 2020 |
Planelles V, Emerman M. Decision letter: HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137 Elife. DOI: 10.7554/Elife.55806.Sa1 |
0.566 |
|
| 2019 |
Trypsteen W, White CH, Mukim A, Spina CA, De Spiegelaere W, Lefever S, Planelles V, Bosque A, Woelk CH, Vandekerckhove L, Beliakova-Bethell N. Long non-coding RNAs and latent HIV - A search for novel targets for latency reversal. Plos One. 14: e0224879. PMID 31710657 DOI: 10.1371/Journal.Pone.0224879 |
0.596 |
|
| 2019 |
Read DF, Atindaana E, Pyaram K, Yang F, Emery S, Cheong A, Nakama KR, Burnett C, Larragoite ET, Battivelli E, Verdin E, Planelles V, Chang CH, Telesnitsky A, Kidd JM. Stable integrant-specific differences in bimodal HIV-1 expression patterns revealed by high-throughput analysis. Plos Pathogens. 15: e1007903. PMID 31584995 DOI: 10.1371/Journal.Ppat.1007903 |
0.546 |
|
| 2019 |
Rodríguez-Mora S, Spivak AM, Szaniawski MA, López-Huertas MR, Alcamí J, Planelles V, Coiras M. Tyrosine Kinase Inhibition: a New Perspective in the Fight against HIV. Current Hiv/Aids Reports. PMID 31506864 DOI: 10.1007/S11904-019-00462-5 |
0.577 |
|
| 2019 |
Hotter D, Bosso M, Jønsson KL, Krapp C, Stürzel CM, Das A, Littwitz-Salomon E, Berkhout B, Russ A, Wittmann S, Gramberg T, Zheng Y, Martins LJ, Planelles V, Jakobsen MR, et al. IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation. Cell Host & Microbe. PMID 31175045 DOI: 10.1016/J.Chom.2019.05.002 |
0.556 |
|
| 2019 |
Morton EL, Forst CV, Zheng Y, DePaula-Silva AB, Ramirez NP, Planelles V, D'Orso I. Transcriptional Circuit Fragility Influences HIV Proviral Fate. Cell Reports. 27: 154-171.e9. PMID 30943398 DOI: 10.1016/J.Celrep.2019.03.007 |
0.479 |
|
| 2019 |
Vigón L, Rodríguez-Mora S, Mateos E, García V, Ambrosioni J, Climent N, Bautista G, Alcamí J, Steegmann JL, Plana M, Miró JM, Planelles V, Huertas MRL, Coiras M. CD4 T cells from patients with chronic myeloid leukemia are resistant to HIV-1 proviral integration and transcription after prolonged withdrawal of treatment with tyrosine kinase inhibitors Journal of Virus Eradication. 5: 53. DOI: 10.1016/S2055-6640(20)30214-4 |
0.466 |
|
| 2019 |
Pache L, Teriete P, Marsden MD, Spivak AM, Heimann D, Portillo AJ, Planelles V, Zack JA, Cosford NDP, Chanda SK. Optimisation of Smac mimetics as HIV-1 latency reversing agents Journal of Virus Eradication. 5: 37. DOI: 10.1016/S2055-6640(20)30171-0 |
0.556 |
|
| 2019 |
Larragoite E, Kimball KE, Atindaana E, Telesnitsky A, Planelles V. Utilising genetic barcodes to understand the role of silent integration in HIV latency Journal of Virus Eradication. 5: 13. DOI: 10.1016/S2055-6640(20)30105-9 |
0.517 |
|
| 2019 |
Hanley T, Planelles V, Viglianti G. Interactions with pathogenic bacteria induce HIV-1 latency in macrophages through altered transcription factor recruitment to the LTR Journal of Virus Eradication. 5: 8. DOI: 10.1016/S2055-6640(20)30090-X |
0.494 |
|
| 2019 |
Planelles V, Szaniawski M, Williams E, Innis E, Martins L, Spivak A, Alcami J, Coiras M. Tyrosine kinase inhibition: the new front in HIV cure efforts Journal of Virus Eradication. 5: 3. DOI: 10.1016/S2055-6640(20)30075-3 |
0.503 |
|
| 2018 |
Szaniawski MA, Spivak AM, Bosque A, Planelles V. Sex influences SAMHD1 activity and susceptibility to HIV-1 in primary human macrophages. The Journal of Infectious Diseases. PMID 30299483 DOI: 10.1093/Infdis/Jiy583 |
0.579 |
|
| 2018 |
Macedo AB, Novis CL, De Assis CM, Sorensen ES, Moszczynski P, Huang SH, Ren Y, Spivak AM, Jones RB, Planelles V, Bosque A. Dual TLR2 and TLR7 agonists as HIV latency-reversing agents. Jci Insight. 3. PMID 30282829 DOI: 10.1172/Jci.Insight.122673 |
0.553 |
|
| 2018 |
Spivak AM, Nell RA, Petersen M, Martins L, Sebahar P, Looper RE, Planelles V. Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency Reversal. Antimicrobial Agents and Chemotherapy. PMID 30104276 DOI: 10.1128/Aac.01361-18 |
0.6 |
|
| 2018 |
Macedo AB, Resop RS, Martins LJ, Szaniawski MA, Sorensen ES, Spivak AM, Nixon DF, Jones RB, Planelles V, Bosque A. Influence of biological sex, age and HIV status in an in vitro primary cell model of HIV latency using a CXCR4 tropic virus. Aids Research and Human Retroviruses. PMID 29926732 DOI: 10.1089/Aid.2018.0098 |
0.612 |
|
| 2018 |
Szaniawski MA, Spivak AM, Cox JE, Catrow JL, Hanley T, Williams ESCP, Tremblay MJ, Bosque A, Planelles V. SAMHD1 Phosphorylation Coordinates the Anti-HIV-1 Response by Diverse Interferons and Tyrosine Kinase Inhibition. Mbio. 9. PMID 29764952 DOI: 10.1128/Mbio.00819-18 |
0.56 |
|
| 2018 |
Abdel-Mohsen M, Kuri-Cervantes L, Grau-Exposito J, Spivak AM, Nell RA, Tomescu C, Vadrevu SK, Giron LB, Serra-Peinado C, Genescà M, Castellví J, Wu G, Del Rio Estrada PM, González-Navarro M, Lynn K, ... ... Planelles V, et al. CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Science Translational Medicine. 10. PMID 29669853 DOI: 10.1126/Scitranslmed.Aar6759 |
0.508 |
|
| 2017 |
Spivak AM, Planelles V. Novel Latency Reversal Agents for HIV-1 Cure. Annual Review of Medicine. PMID 29099677 DOI: 10.1146/Annurev-Med-052716-031710 |
0.581 |
|
| 2017 |
Larson EC, Novis CL, Martins LJ, Macedo AB, Kimball KE, Bosque A, Planelles V, Barrows LR. Mycobacterium tuberculosis reactivates latent HIV-1 in T cells in vitro. Plos One. 12: e0185162. PMID 28949981 DOI: 10.1371/Journal.Pone.0185162 |
0.625 |
|
| 2017 |
Bosque A, Nilson KA, Macedo AB, Spivak AM, Archin NM, Van Wagoner RM, Martins LJ, Novis CL, Szaniawski MA, Ireland CM, Margolis DM, Price DH, Planelles V. Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation. Cell Reports. 18: 1324-1334. PMID 28147284 DOI: 10.1016/J.Celrep.2017.01.022 |
0.62 |
|
| 2017 |
Novis CL, Sarabia I, Macedo AB, Nell R, Shakya B, Schubert HL, Hill CP, Paula-Silva ABD, Spivak AM, Planelles V, Bosque A. Role of mitochondrial antiviral signaling protein in reactivation of latent HIV-1 in CD4+ T cells Journal of Virus Eradication. 3: 58. DOI: 10.1016/S2055-6640(20)30676-2 |
0.506 |
|
| 2017 |
Szaniawski M, Spivak A, Bosque A, Planelles V. Diverse interferons restrict HIV-1 Infection in macrophages through activation of SAMHD1 Journal of Virus Eradication. 3: 33. DOI: 10.1016/S2055-6640(20)30641-5 |
0.56 |
|
| 2017 |
Macedo A, Martins LJ, Spivak AM, Szaniawski MA, Planelles V, Bosque A. Influence of Sex as an Intrinsic Biological Variable in a Primary Cell Model of HIV Latency Journal of Virus Eradication. 3: 19. DOI: 10.1016/S2055-6640(20)30597-5 |
0.552 |
|
| 2017 |
Larragoite E, Williams E, Planelles V. Using barcoded HIV-1 to understand inducibility of the latent HIV-1 reservoir Journal of Virus Eradication. 3: 13. DOI: 10.1016/S2055-6640(20)30592-6 |
0.588 |
|
| 2017 |
Macedo AB, Novis CL, Spivak AM, Planelles V, Huang JS, Ren Y, Jones RB, Bosque A. Direct and indirect effects of synthetic dual TLR-2 and TLR-7 agonists (Dual TLR-2/7) on latent HIV Journal of Virus Eradication. 3: 56. DOI: 10.1016/S2055-6640(20)30568-9 |
0.436 |
|
| 2017 |
Abdel-Mohsen M, Tomescu C, Vadrevu S, Spivak A, Kuri-Cervantes L, Wu G, Cox K, Vemula S, Fair M, Lynn K, Buzon MJ, Martinez-Picado J, Betts M, Planelles V, Mounzer K, et al. CD32+ CD4+ T Cells are HIV transcriptionally active rather than a resting reservoir Journal of Virus Eradication. 3: 9. DOI: 10.1016/S2055-6640(20)30531-8 |
0.462 |
|
| 2017 |
Spivak AM, Nell RA, Coletti ML, Montaner LJ, Planelles V. CD4+ T cells expressing CD32 from HIV-1-positive patients are not enriched for proviral DNA Journal of Virus Eradication. 3: 8-9. DOI: 10.1016/S2055-6640(20)30529-X |
0.456 |
|
| 2016 |
Spivak AM, Larragoite ET, Coletti ML, Macedo AB, Martins LJ, Bosque A, Planelles V. Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo. Retrovirology. 13: 88. PMID 27998278 DOI: 10.1186/S12977-016-0319-0 |
0.519 |
|
| 2016 |
White CH, Moesker B, Beliakova-Bethell N, Martins LJ, Spina CA, Margolis DM, Richman DD, Planelles V, Bosque A, Woelk CH. Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model. Plos Pathogens. 12: e1006026. PMID 27898737 DOI: 10.1371/Journal.Ppat.1006026 |
0.642 |
|
| 2016 |
Garrido C, Spivak AM, Soriano-Sarabia N, Checkley MA, Barker E, Karn J, Planelles V, Margolis DM. HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function. Frontiers in Immunology. 7: 356. PMID 27708642 DOI: 10.3389/Fimmu.2016.00356 |
0.568 |
|
| 2016 |
Larson EC, Pond CD, Szaniawski MA, Martins LJ, Planelles V, Barrows LR. Macrophage Cell Coinfected with HIV-1 and H37Ra. Aids Research and Human Retroviruses. PMID 27309672 DOI: 10.1089/Aid.2016.0067 |
0.59 |
|
| 2016 |
Davis ZB, Sowrirajan B, Cogswell A, Ward JP, Planelles V, Barker E. CD155 on HIV-infected cells is not modulated by HIV-1 Vpu and Nef but synergizes with NKG2D ligands to trigger NK cell lysis of autologous primary HIV-infected cells. Aids Research and Human Retroviruses. PMID 27296670 DOI: 10.1089/Aid.2015.0375 |
0.548 |
|
| 2016 |
Sunshine S, Kirchner R, Amr SS, Mansur L, Shakhbatyan R, Kim M, Bosque A, Siliciano RF, Planelles V, Hofmann O, Ho Sui S, Li JZ. HIV Integration Site Analysis of Cellular Models of HIV Latency with a Probe-Enriched Next-Generation Sequencing Assay. Journal of Virology. PMID 26912621 DOI: 10.1128/Jvi.01617-15 |
0.576 |
|
| 2016 |
Davis ZB, Cogswell A, Scott H, Mertsching A, Boucau J, Wambua D, Le Gall S, Planelles V, Campbell KS, Barker E. A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells. Plos Pathogens. 12: e1005421. PMID 26828202 DOI: 10.1371/Journal.Ppat.1005421 |
0.507 |
|
| 2016 |
Spivak AM, Planelles V. HIV-1 Eradication: Early Trials (and Tribulations). Trends in Molecular Medicine. 22: 10-27. PMID 26691297 DOI: 10.1016/J.Molmed.2015.11.004 |
0.601 |
|
| 2015 |
Saayman SM, Lazar DC, Scott TA, Hart JR, Takahashi M, Burnett JC, Planelles V, Morris KV, Weinberg MS. Potent and targeted activation of latent HIV-1 using the CRISPR/dCas9 activator complex. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26581162 DOI: 10.1038/Mt.2015.202 |
0.574 |
|
| 2015 |
Pache L, Dutra MS, Spivak AM, Marlett JM, Murry JP, Hwang Y, Maestre AM, Manganaro L, Vamos M, Teriete P, Martins LJ, König R, Simon V, Bosque A, Fernandez-Sesma A, ... ... Planelles V, et al. BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency. Cell Host & Microbe. 18: 345-53. PMID 26355217 DOI: 10.1016/J.Chom.2015.08.009 |
0.593 |
|
| 2015 |
Planelles V. An Ounce of Tat Prevention Is Worth a Pound of Functional Cure. Mbio. 6. PMID 26286696 DOI: 10.1128/Mbio.01269-15 |
0.518 |
|
| 2015 |
Ramirez PW, DePaula-Silva AB, Szaniawski M, Barker E, Bosque A, Planelles V. HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins. Retrovirology. 12: 65. PMID 26215564 DOI: 10.1186/S12977-015-0192-2 |
0.465 |
|
| 2015 |
Martins LJ, Bonczkowski P, Spivak AM, De Spiegelaere W, Novis CL, DePaula-Silva AB, Malatinkova E, Typsteen W, Bosque A, Vanderkerckhove L, Planelles V. Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus. Aids Research and Human Retroviruses. PMID 26171776 DOI: 10.1089/aid.2015.0106 |
0.53 |
|
| 2015 |
Spivak AM, Bosque A, Balch AH, Smyth D, Martins L, Planelles V. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients. Antimicrobial Agents and Chemotherapy. 59: 5984-91. PMID 26169416 DOI: 10.1128/Aac.01077-15 |
0.598 |
|
| 2015 |
DePaula-Silva AB, Cassiday PA, Chumley J, Bosque A, Monteiro-Filho CM, Mahon CS, Cone KR, Krogan N, Elde NC, Planelles V. Determinants for degradation of SAMHD1, Mus81 and induction of G2 arrest in HIV-1 Vpr and SIVagm Vpr. Virology. 477: 10-7. PMID 25618414 DOI: 10.1016/J.Virol.2014.12.040 |
0.559 |
|
| 2015 |
Cassiday PA, DePaula-Silva AB, Chumley J, Ward J, Barker E, Planelles V. Understanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx. Virology. 476: 19-25. PMID 25499532 DOI: 10.1016/J.Virol.2014.11.024 |
0.444 |
|
| 2015 |
Gunawardana YP, Beliakova-Bethell N, Spina C, Margolis D, Bosque A, Planelles V, Woelk CH. The utility of the Connectivity Map (CMAP) for HIV cure strategies Journal of Virus Eradication. 1: 37-38. DOI: 10.1016/S2055-6640(20)31404-7 |
0.502 |
|
| 2015 |
Planelles V, Spivak AM, Larragoite ET, Novis CL, Bosque LJMA. Ingenol derivatives are potent reactivators of latent HIV Journal of Virus Eradication. 1: 22. DOI: 10.1016/S2055-6640(20)31355-8 |
0.582 |
|
| 2015 |
Bosque A, Macedo A, Spivak A, Novis CL, Martins LJ, Szaniawski M, Archin NM, Luciw PA, Margolis DM, Planelles V. Triazol-1-ol analogues as novel therapeutic leads towards reactivating and eradicating latent HIV-1 by manipulating SUMOylation of STAT5 Journal of Virus Eradication. 1: 12. DOI: 10.1016/S2055-6640(20)31325-X |
0.582 |
|
| 2015 |
Woelk CH, White CH, Bosque A, Moesker B, Spina CA, Richman DD, Beliakova-Bethell N, Planelles V. Shining the RNA-Seq microscope on models of HIV latency Journal of Virus Eradication. 1: 1-2. DOI: 10.1016/S2055-6640(20)31278-4 |
0.49 |
|
| 2014 |
Murry JP, Godoy J, Mukim A, Swann J, Bruce JW, Ahlquist P, Bosque A, Planelles V, Spina CA, Young JA. Sulfonation pathway inhibitors block reactivation of latent HIV-1. Virology. 471: 1-12. PMID 25310595 DOI: 10.1016/J.Virol.2014.08.016 |
0.57 |
|
| 2014 |
Bonczkowski P, De Spiegelaere W, Bosque A, White CH, Van Nuffel A, Malatinkova E, Kiselinova M, Trypsteen W, Witkowski W, Vermeire J, Verhasselt B, Martins L, Woelk CH, Planelles V, Vandekerckhove L. Replication competent virus as an important source of bias in HIV latency models utilizing single round viral constructs. Retrovirology. 11: 70. PMID 25142072 DOI: 10.1186/S12977-014-0070-3 |
0.562 |
|
| 2014 |
Ramirez PW, Famiglietti M, Sowrirajan B, DePaula-Silva AB, Rodesch C, Barker E, Bosque A, Planelles V. Downmodulation of CCR7 by HIV-1 Vpu results in impaired migration and chemotactic signaling within CD4⁺ T cells. Cell Reports. 7: 2019-30. PMID 24910430 DOI: 10.1016/J.Celrep.2014.05.015 |
0.523 |
|
| 2014 |
Saayman S, Ackley A, Turner AM, Famiglietti M, Bosque A, Clemson M, Planelles V, Morris KV. An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1164-75. PMID 24576854 DOI: 10.1038/Mt.2014.29 |
0.372 |
|
| 2014 |
Gavegnano C, Detorio M, Montero C, Bosque A, Planelles V, Schinazi RF. Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro. Antimicrobial Agents and Chemotherapy. 58: 1977-86. PMID 24419350 DOI: 10.1128/Aac.02496-13 |
0.628 |
|
| 2014 |
Duverger A, Wolschendorf F, Anderson JC, Wagner F, Bosque A, Shishido T, Jones J, Planelles V, Willey C, Cron RQ, Kutsch O. Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation. Journal of Virology. 88: 364-76. PMID 24155393 DOI: 10.1128/Jvi.02682-13 |
0.619 |
|
| 2013 |
Spina CA, Anderson J, Archin NM, Bosque A, Chan J, Famiglietti M, Greene WC, Kashuba A, Lewin SR, Margolis DM, Mau M, Ruelas D, Saleh S, Shirakawa K, Siliciano RF, ... ... Planelles V, et al. An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients. Plos Pathogens. 9: e1003834. PMID 24385908 DOI: 10.1371/Journal.Ppat.1003834 |
0.568 |
|
| 2013 |
Novis CL, Archin NM, Buzon MJ, Verdin E, Round JL, Lichterfeld M, Margolis DM, Planelles V, Bosque A. Reactivation of latent HIV-1 in central memory CD4⺠T cells through TLR-1/2 stimulation. Retrovirology. 10: 119. PMID 24156240 DOI: 10.1186/1742-4690-10-119 |
0.467 |
|
| 2013 |
Sherrill-Mix S, Lewinski MK, Famiglietti M, Bosque A, Malani N, Ocwieja KE, Berry CC, Looney D, Shan L, Agosto LM, Pace MJ, Siliciano RF, O'Doherty U, Guatelli J, Planelles V, et al. HIV latency and integration site placement in five cell-based models. Retrovirology. 10: 90. PMID 23953889 DOI: 10.1186/1742-4690-10-90 |
0.523 |
|
| 2013 |
Boehm D, Calvanese V, Dar RD, Xing S, Schroeder S, Martins L, Aull K, Li PC, Planelles V, Bradner JE, Zhou MM, Siliciano RF, Weinberger L, Verdin E, Ott M. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Cell Cycle (Georgetown, Tex.). 12: 452-62. PMID 23255218 DOI: 10.4161/Cc.23309 |
0.626 |
|
| 2013 |
Budhiraja S, Famiglietti M, Bosque A, Planelles V, Rice AP. Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells. Journal of Virology. 87: 1211-20. PMID 23152527 DOI: 10.1128/Jvi.02413-12 |
0.456 |
|
| 2012 |
de Silva S, Planelles V, Wu L. Differential effects of Vpr on single-cycle and spreading HIV-1 infections in CD4+ T-cells and dendritic cells. Plos One. 7: e35385. PMID 22570689 DOI: 10.1371/Journal.Pone.0035385 |
0.639 |
|
| 2012 |
Wolschendorf F, Bosque A, Shishido T, Duverger A, Jones J, Planelles V, Kutsch O. Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity. Journal of Virology. 86: 4548-58. PMID 22345467 DOI: 10.1128/Jvi.06726-11 |
0.608 |
|
| 2012 |
Planelles V. SAMHD1 Joins the red Queen's court. Cell Host & Microbe. 11: 103-5. PMID 22341459 DOI: 10.1016/J.Chom.2012.02.001 |
0.338 |
|
| 2012 |
Planelles V, Bosque A. HIV-1 Latency in Memory T cells Journal of Antivirals & Antiretrovirals. 1. DOI: 10.4172/1948-5964.S1.005 |
0.511 |
|
| 2011 |
Planelles V, Wolschendorf F, Kutsch O. Facts and fiction: cellular models for high throughput screening for HIV-1 reactivating drugs. Current Hiv Research. 9: 568-78. PMID 22211661 DOI: 10.2174/157016211798998826 |
0.575 |
|
| 2011 |
Bosque A, Famiglietti M, Weyrich AS, Goulston C, Planelles V. Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells. Plos Pathogens. 7: e1002288. PMID 21998586 DOI: 10.1371/Journal.Ppat.1002288 |
0.521 |
|
| 2011 |
Planelles V. Restricted access to myeloid cells explained. Viruses. 3: 1624-33. PMID 21994799 DOI: 10.3390/V3091624 |
0.335 |
|
| 2011 |
Bosque A, Planelles V. Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells. Methods (San Diego, Calif.). 53: 54-61. PMID 20970502 DOI: 10.1016/J.Ymeth.2010.10.002 |
0.63 |
|
| 2010 |
Shah AH, Sowrirajan B, Davis ZB, Ward JP, Campbell EM, Planelles V, Barker E. Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host & Microbe. 8: 397-409. PMID 21075351 DOI: 10.1016/J.Chom.2010.10.008 |
0.519 |
|
| 2010 |
Planelles V, Barker E. Roles of Vpr and Vpx in modulating the virus-host cell relationship. Molecular Aspects of Medicine. 31: 398-406. PMID 20558198 DOI: 10.1016/J.Mam.2010.05.002 |
0.376 |
|
| 2010 |
Bosque A, Planelles V. Homeostatic proliferation of memory T cells and expansion of the HIV-1 latent reservoir Journal of the International Aids Society. 13: O6. DOI: 10.1186/1758-2652-13-S3-O6 |
0.422 |
|
| 2009 |
Planelles V, Benichou S. Vpr and its interactions with cellular proteins. Current Topics in Microbiology and Immunology. 339: 177-200. PMID 20012529 DOI: 10.1007/978-3-642-02175-6_9 |
0.479 |
|
| 2009 |
Jacquot G, Le Rouzic E, Maidou-Peindara P, Maizy M, Lefrère JJ, Daneluzzi V, Monteiro-Filho CM, Hong D, Planelles V, Morand-Joubert L, Benichou S. Characterization of the molecular determinants of primary HIV-1 Vpr proteins: impact of the Q65R and R77Q substitutions on Vpr functions. Plos One. 4: e7514. PMID 19838296 DOI: 10.1371/Journal.Pone.0007514 |
0.503 |
|
| 2009 |
Ward J, Davis Z, DeHart J, Zimmerman E, Bosque A, Brunetta E, Mavilio D, Planelles V, Barker E. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. Plos Pathogens. 5: e1000613. PMID 19798433 DOI: 10.1371/Journal.Ppat.1000613 |
0.576 |
|
| 2009 |
Rosenstiel PE, Chan J, Snyder A, Planelles V, D'Agati VD, Klotman PE, Klotman ME. HIV-1 Vpr activates the DNA damage response in renal tubule epithelial cells. Aids (London, England). 23: 2054-6. PMID 19657269 DOI: 10.1097/Qad.0B013E32833088A0 |
0.428 |
|
| 2009 |
Kauder SE, Bosque A, Lindqvist A, Planelles V, Verdin E. Epigenetic regulation of HIV-1 latency by cytosine methylation. Plos Pathogens. 5: e1000495. PMID 19557157 DOI: 10.1371/Journal.Ppat.1000495 |
0.575 |
|
| 2009 |
Bosque A, Planelles V. Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood. 113: 58-65. PMID 18849485 DOI: 10.1182/Blood-2008-07-168393 |
0.597 |
|
| 2008 |
Andjelic CD, Planelles V, Barrows LR. Characterizing the anti-HIV activity of papuamide A. Marine Drugs. 6: 528-49. PMID 19172193 DOI: 10.3390/Md20080027 |
0.592 |
|
| 2008 |
Rosenstiel PE, Gruosso T, Letourneau AM, Chan JJ, LeBlanc A, Husain M, Najfeld V, Planelles V, D'Agati VD, Klotman ME, Klotman PE. HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells. Kidney International. 74: 1049-58. PMID 18614999 DOI: 10.1038/Ki.2008.303 |
0.568 |
|
| 2008 |
DeHart JL, Bosque A, Harris RS, Planelles V. Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation. Journal of Virology. 82: 9265-72. PMID 18596088 DOI: 10.1128/Jvi.00377-08 |
0.507 |
|
| 2008 |
Andersen JL, Le Rouzic E, Planelles V. HIV-1 Vpr: mechanisms of G2 arrest and apoptosis. Experimental and Molecular Pathology. 85: 2-10. PMID 18514189 DOI: 10.1016/J.Yexmp.2008.03.015 |
0.622 |
|
| 2008 |
Chugh P, Bradel-Tretheway B, Monteiro-Filho CM, Planelles V, Maggirwar SB, Dewhurst S, Kim B. Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy. Retrovirology. 5: 11. PMID 18237430 DOI: 10.1186/1742-4690-5-11 |
0.604 |
|
| 2008 |
Dehart JL, Planelles V. Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation. Journal of Virology. 82: 1066-72. PMID 17855541 DOI: 10.1128/Jvi.01628-07 |
0.361 |
|
| 2007 |
Lama J, Planelles V. Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology. 4: 52. PMID 17651505 DOI: 10.1186/1742-4690-4-52 |
0.549 |
|
| 2007 |
DeHart JL, Zimmerman ES, Ardon O, Monteiro-Filho CM, Argañaraz ER, Planelles V. HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system. Virology Journal. 4: 57. PMID 17559673 DOI: 10.1186/1743-422X-4-57 |
0.432 |
|
| 2007 |
Chugh P, Fan S, Planelles V, Maggirwar SB, Dewhurst S, Kim B. Infection of human immunodeficiency virus and intracellular viral Tat protein exert a pro-survival effect in a human microglial cell line. Journal of Molecular Biology. 366: 67-81. PMID 17157319 DOI: 10.1016/J.Jmb.2006.11.011 |
0.631 |
|
| 2007 |
Dykes C, Wang J, Jin X, Planelles V, Dong SA, Tallo A, Huang Y, Wu H, Demeter LM. Erratum: Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture (Journal of Clinical Microbiology (2006) 44, 6, (1930-1943)) Journal of Clinical Microbiology. 45. DOI: 10.1128/Jcm.00821-07 |
0.354 |
|
| 2006 |
Andersen JL, DeHart JL, Zimmerman ES, Ardon O, Kim B, Jacquot G, Benichou S, Planelles V. HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT. Plos Pathogens. 2: e127. PMID 17140287 DOI: 10.1371/Journal.Ppat.0020127 |
0.43 |
|
| 2006 |
Zimmerman ES, Sherman MP, Blackett JL, Neidleman JA, Kreis C, Mundt P, Williams SA, Warmerdam M, Kahn J, Hecht FM, Grant RM, de Noronha CM, Weyrich AS, Greene WC, Planelles V. Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo. Journal of Virology. 80: 10407-18. PMID 16956949 DOI: 10.1128/Jvi.01212-06 |
0.601 |
|
| 2006 |
Choudhary SK, Walker RM, Powell DM, Planelles V, Walsh C, Camerini D. CXCR4 tropic human immunodeficiency virus type 1 induces an apoptotic cascade in immature infected thymocytes that resembles thymocyte negative selection. Virology. 352: 268-84. PMID 16777169 DOI: 10.1016/J.Virol.2006.04.037 |
0.571 |
|
| 2006 |
Dykes C, Wang J, Jin X, Planelles V, An DS, Tallo A, Huang Y, Wu H, Demeter LM. Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture. Journal of Clinical Microbiology. 44: 1930-43. PMID 16757582 DOI: 10.1128/Jcm.02415-05 |
0.54 |
|
| 2006 |
Ardon O, Zimmerman ES, Andersen JL, DeHart JL, Blackett J, Planelles V. Induction of G2 arrest and binding to cyclophilin A are independent phenotypes of human immunodeficiency virus type 1 Vpr. Journal of Virology. 80: 3694-700. PMID 16571786 DOI: 10.1128/Jvi.80.8.3694-3700.2006 |
0.415 |
|
| 2006 |
Zeng L, Planelles V, Sui Z, Gartner S, Maggirwar SB, Dewhurst S, Ye L, Nerurkar VR, Yanagihara R, Lu Y. HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1. The Journal of Gene Medicine. 8: 18-28. PMID 16142830 DOI: 10.1002/Jgm.825 |
0.614 |
|
| 2005 |
Lai M, Zimmerman ES, Planelles V, Chen J. Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo. Journal of Virology. 79: 15443-51. PMID 16306615 DOI: 10.1128/Jvi.79.24.15443-15451.2005 |
0.484 |
|
| 2005 |
Tripp A, Banerjee P, Sieburg M, Planelles V, Li F, Feuer G. Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34+) cells: modulation of p21cip1/waf1 and p27kip1 expression. Journal of Virology. 79: 14069-78. PMID 16254341 DOI: 10.1128/Jvi.79.22.14069-14078.2005 |
0.373 |
|
| 2005 |
Strayer DS, Akkina R, Bunnell BA, Dropulic B, Planelles V, Pomerantz RJ, Rossi JJ, Zaia JA. Current status of gene therapy strategies to treat HIV/AIDS. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 823-42. PMID 15922953 DOI: 10.1016/J.Ymthe.2005.01.020 |
0.585 |
|
| 2005 |
Andersen JL, Zimmerman ES, DeHart JL, Murala S, Ardon O, Blackett J, Chen J, Planelles V. ATR and GADD45α mediate HIV-1 Vpr-induced apoptosis Cell Death and Differentiation. 12: 326-334. PMID 15650754 DOI: 10.1038/Sj.Cdd.4401565 |
0.543 |
|
| 2005 |
Dehart JL, Andersen JL, Zimmerman ES, Ardon O, An DS, Blackett J, Kim B, Planelles V. The ataxia telangiectasia-mutated and Rad3-related protein is dispensable for retroviral integration. Journal of Virology. 79: 1389-96. PMID 15650165 DOI: 10.1128/Jvi.79.3.1389-1396.2005 |
0.334 |
|
| 2005 |
Andersen JL, Planelles V. The role of Vpr in HIV-1 pathogenesis. Current Hiv Research. 3: 43-51. PMID 15638722 DOI: 10.2174/1570162052772988 |
0.64 |
|
| 2005 |
Mojica-Henshaw MP, Pierce LJ, Phillips JD, Planelles V, Spangrude GJ. Clonal Marking of Mouse Hematopoietic Stem and Lymphoid Progenitor Cell Populations. Blood. 106: 5544-5544. DOI: 10.1182/Blood.V106.11.5544.5544 |
0.332 |
|
| 2004 |
Renda MJ, Bradel-Tretheway B, Planelles V, Bambara RA, Dewhurst S. Inhibition of HIV type 1 replication using lentiviral-mediated delivery of mutant tRNA(Lys3)A58U. Aids Research and Human Retroviruses. 20: 1324-34. PMID 15650425 DOI: 10.1089/Aid.2004.20.1324 |
0.603 |
|
| 2004 |
Zimmerman ES, Chen J, Andersen JL, Ardon O, Dehart JL, Blackett J, Choudhary SK, Camerini D, Nghiem P, Planelles V. Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation. Molecular and Cellular Biology. 24: 9286-94. PMID 15485898 DOI: 10.1128/Mcb.24.21.9286-9294.2004 |
0.572 |
|
| 2004 |
Diamond TL, Roshal M, Jamburuthugoda VK, Reynolds HM, Merriam AR, Lee KY, Balakrishnan M, Bambara RA, Planelles V, Dewhurst S, Kim B. Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. The Journal of Biological Chemistry. 279: 51545-53. PMID 15452123 DOI: 10.1074/Jbc.M408573200 |
0.627 |
|
| 2004 |
Dykes C, Balakrishnan M, Planelles V, Zhu Y, Bambara RA, Demeter LM. Identification of a preferred region for recombination and mutation in HIV-1 gag. Virology. 326: 262-79. PMID 15302212 DOI: 10.1016/J.Virol.2004.02.033 |
0.558 |
|
| 2004 |
Dykes C, Balakrishnan M, Planelles V, Zhu Y, Bambara RA, Demeter LM. Erratum to “Identification of a preferred region for recombination and mutation in HIV-1 gag ” [Virology 326 (2004) 262–279] Virology. 329: 513. DOI: 10.1016/J.Virol.2004.09.018 |
0.646 |
|
| 2003 |
Lu Y, Liu C, Zeng L, Lin Z, Dewhurst S, Gartner S, Planelles V. Efficient gene transfer into human monocyte-derived macrophages using defective lentiviral vectors Cellular and Molecular Biology (Noisy-Le-Grand, France). 49: 1151-1156. PMID 14682398 |
0.394 |
|
| 2003 |
Anderson J, Banerjea A, Planelles V, Akkina R. Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA. Aids Research and Human Retroviruses. 19: 699-706. PMID 13678472 DOI: 10.1089/088922203322280928 |
0.617 |
|
| 2003 |
Roshal M, Kim B, Zhu Y, Nghiem P, Planelles V. Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R. The Journal of Biological Chemistry. 278: 25879-86. PMID 12738771 DOI: 10.1074/Jbc.M303948200 |
0.696 |
|
| 2003 |
Zhu Y, Planelles V. A multigene lentiviral vector system based on differential splicing. Methods in Molecular Medicine. 76: 433-48. PMID 12526178 DOI: 10.1385/1-59259-304-6:433 |
0.46 |
|
| 2003 |
Zhu Y, Roshal M, Li F, Blackett J, Planelles V. Upregulation of survivin by HIV-1 Vpr. Apoptosis : An International Journal On Programmed Cell Death. 8: 71-9. PMID 12510154 DOI: 10.1023/A:1021653119934 |
0.686 |
|
| 2001 |
Pandya S, Klimatcheva E, Planelles V. Lentivirus and foamy virus vectors: novel gene therapy tools. Expert Opinion On Biological Therapy. 1: 17-40. PMID 11727544 DOI: 10.1517/14712598.1.1.17 |
0.351 |
|
| 2001 |
Zhu Y, Feuer G, Day SL, Wrzesinski S, Planelles V. Multigene lentiviral vectors based on differential splicing and translational control. Molecular Therapy : the Journal of the American Society of Gene Therapy. 4: 375-82. PMID 11592842 DOI: 10.1006/Mthe.2001.0469 |
0.583 |
|
| 2001 |
Renda MJ, Rosenblatt JD, Klimatcheva E, Demeter LM, Bambara RA, Planelles V. Mutation of the methylated tRNA(Lys)(3) residue A58 disrupts reverse transcription and inhibits replication of human immunodeficiency virus type 1. Journal of Virology. 75: 9671-8. PMID 11559799 DOI: 10.1128/Jvi.75.20.9671-9678.2001 |
0.472 |
|
| 2001 |
Klimatcheva E, Planelles V, Day SL, Fulreader F, Renda MJ, Rosenblatt J. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication. Molecular Therapy : the Journal of the American Society of Gene Therapy. 3: 928-39. PMID 11407907 DOI: 10.1006/Mthe.2001.0344 |
0.627 |
|
| 2001 |
Pandya S, Boris-Lawrie K, Leung NJ, Akkina R, Planelles V. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system Human Gene Therapy. 12: 847-857. PMID 11339901 DOI: 10.1089/104303401750148847 |
0.575 |
|
| 2001 |
Roshal M, Zhu Y, Planelles V. Apoptosis in AIDS. Apoptosis : An International Journal On Programmed Cell Death. 6: 103-16. PMID 11321033 DOI: 10.1023/A:1009636530839 |
0.723 |
|
| 2001 |
Zhu Y, Gelbard HA, Roshal M, Pursell S, Jamieson BD, Planelles V. Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes. Journal of Virology. 75: 3791-801. PMID 11264368 DOI: 10.1128/Jvi.75.8.3791-3801.2001 |
0.714 |
|
| 2000 |
Wrzesinski S, Seguin R, Liu Y, Domville S, Planelles V, Massa P, Barker E, Antel J, Feuer G. HTLV type 1 tax transduction in microglial cells and astrocytes by lentiviral vectors Aids Research and Human Retroviruses. 16: 1771-1776. PMID 11080825 DOI: 10.1089/08892220050193290 |
0.406 |
|
| 2000 |
Toy EP, Rodríguez-Rodríguez L, McCance D, Ludlow J, Planelles V. Induction of cell-cycle arrest in cervical cancer cells by the human immunodeficiency virus type 1 viral protein R Obstetrics and Gynecology. 95: 141-146. PMID 10636517 DOI: 10.1016/S0029-7844(99)00464-0 |
0.335 |
|
| 1999 |
Dreyer K, Kallas EG, Planelles V, Montefiori D, McDermott MP, Hasan MS, Evans TG. Primary isolate neutralization by HIV type 1-infected patient sera in the era of highly active antiretroviral therapy Aids Research and Human Retroviruses. 15: 1563-1571. PMID 10580407 DOI: 10.1089/088922299309856 |
0.576 |
|
| 1999 |
Shostak LD, Ludlow J, Fisk J, Pursell S, Rimel BJ, Nguyen D, Rosenblatt JD, Planelles V. Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr Experimental Cell Research. 251: 156-165. PMID 10438581 DOI: 10.1006/Excr.1999.4568 |
0.488 |
|
| 1999 |
Klimatcheva E, Rosenblatt JD, Planelles V. Lentiviral vectors and gene therapy Frontiers in Bioscience : a Journal and Virtual Library. 4. PMID 10352135 DOI: 10.2741/Klimatcheva |
0.354 |
|
| 1999 |
White SM, Renda M, Nam NY, Klimatcheva E, Zhu Y, Fisk J, Halterman M, Rimel BJ, Federoff H, Pandya S, Rosenblatt JD, Planelles V. Lentivirus vectors using human and simian immunodeficiency virus elements. Journal of Virology. 73: 2832-40. PMID 10074131 DOI: 10.1128/Jvi.73.4.2832-2840.1999 |
0.721 |
|
| 1999 |
TOY E, RODRIGUEZ L, MCCANCE D, LUDLOW J, PLANELLES V. Human immunodeficiency virus type I viral protein R (VPR) induces cell-cycle arrest in cervical cancer cells Obstetrics & Gynecology. 93: S12. DOI: 10.1016/S0029-7844(99)90021-2 |
0.379 |
|
| 1998 |
Challita-Eid PM, Klimatcheva E, Day BT, Evans T, Dreyer K, Rimel BJ, Rosenblatt JD, Planelles V. Inhibition of HIV type 1 infection with a RANTES-IgG3 fusion protein Aids Research and Human Retroviruses. 14: 1617-1624. PMID 9870314 DOI: 10.1089/Aid.1998.14.1617 |
0.594 |
|
| 1998 |
LaCasse RA, Follis KE, Moudgil T, Trahey M, Binley JM, Planelles V, Zolla-Pazner S, Nunberg JH. Coreceptor utilization by human immunodeficiency virus type 1 is not a primary determinant of neutralization sensitivity Journal of Virology. 72: 2491-2495. PMID 9499111 DOI: 10.1128/Jvi.72.3.2491-2495.1998 |
0.357 |
|
| 1997 |
Ferreira OC, Planelles V, Rosenblatt JD. Human T-cell leukemia viruses: Epidemiology, biology, and pathogenesis Blood Reviews. 11: 91-104. PMID 9242992 DOI: 10.1016/S0268-960X(97)90015-1 |
0.348 |
|
| 1997 |
Lu Y, Planelles V, Li X, Palaniappan C, Day B, Challita-Eid P, Amado R, Stephens D, Kohn DB, Bakker A, Fay P, Bambara RA, Rosenblatt JD. Inhibition of HIV-1 replication using a mutated tRNALys-3 primer. The Journal of Biological Chemistry. 272: 14523-31. PMID 9169409 DOI: 10.1074/Jbc.272.23.14523 |
0.598 |
|
| 1996 |
Akkina RK, Walton RM, Chen ML, Li QX, Planelles V, Chen ISY. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G Journal of Virology. 70: 2581-2585. PMID 8642689 DOI: 10.1128/Jvi.70.4.2581-2585.1996 |
0.524 |
|
| 1996 |
Planelles V, Jowett JBM, Li QX, Xie Y, Hahn B, Chen ISY. Vpr-induced cell cycle arrest is conserved among primate lentiviruses Journal of Virology. 70: 2516-2524. PMID 8642681 DOI: 10.1128/Jvi.70.4.2516-2524.1996 |
0.632 |
|
| 1995 |
Jowett JBM, Planelles V, Poon B, Shah NP, Chen ML, Chen ISY. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle Journal of Virology. 69: 6304-6313. PMID 7666531 DOI: 10.1128/Jvi.69.10.6304-6313.1995 |
0.594 |
|
| 1995 |
Planelles V, Bachelerie F, Jowett JBM, Haislip A, Xie Y, Banooni P, Masuda T, Chen ISY. Fate of the human immunodeficiency virus type 1 provirus in infected cells: A role for vpr Journal of Virology. 69: 5883-5889. PMID 7637036 DOI: 10.1128/Jvi.69.9.5883-5889.1995 |
0.63 |
|
| 1995 |
Planelles V, Haislip A, Withers-Ward ES, Stewart SA, Xie Y, Shah NP, Chen ISY. A new reporter system for detection of retroviral infection Gene Therapy. 2: 369-376. PMID 7584111 |
0.395 |
|
| 1995 |
Masuda T, Planelles V, Krogstad P, Chen ISY. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: Unusual phenotype of mutants in the zinc finger-like domain Journal of Virology. 69: 6687-6696. PMID 7474078 DOI: 10.1128/Jvi.69.11.6687-6696.1995 |
0.453 |
|
| 1994 |
Jamieson BD, Aldrovandi GM, Planelles V, Jowett JB, Gao L, Bloch LM, Chen IS, Zack JA. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. Journal of Virology. 68: 3478-85. PMID 8189487 DOI: 10.1128/Jvi.68.6.3478-3485.1994 |
0.623 |
|
| 1994 |
Camerini D, Planelles V, Chen IS. CD26 antigen and HIV fusion? Science. 264: 1160-1161; discussio. PMID 7909961 DOI: 10.1126/Science.7909959 |
0.517 |
|
| 1992 |
Luciw PA, Shaw KES, Unger RE, Planelles V, Stout MW, Lackner JE, Pratt-Lowe E, Leung NJ, Banapour B, Marthas ML. Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIV(MAC)) Aids Research and Human Retroviruses. 8: 395-402. PMID 1571198 DOI: 10.1089/Aid.1992.8.395 |
0.449 |
|
| 1992 |
Haigwood NL, Misher L, Chin SM, Blair M, Planelles V, Scandella CJ, Steimer KS, Gardner MB, Yilma T, Hirsch VM. Characterization of group specific antibodies in primates: studies with SIV envelope in macaques Journal of Medical Primatology. 21: 82-90. PMID 1433271 DOI: 10.1111/J.1600-0684.1992.Tb00572.X |
0.37 |
|
| 1991 |
Planelles V, Haigwood NL, Marthas ML, Mann KA, Scandella C, Lidster WD, Shuster JR, Van Kuyk R, Marx PA, Gardner MB, Luciw PA. Functional and immunological characterization of SIV envelope glycoprotein produced in genetically engineered mammalian cells Aids Research and Human Retroviruses. 7: 889-898. PMID 1760229 DOI: 10.1089/Aid.1991.7.889 |
0.371 |
|
| 1991 |
Van Kuyk RW, Acevedo RA, Torres JV, Levy NB, Planelles V, Munn RJ, Unger RE, Gardner MB, Luciw PA. Characterization of rhesus macaque B-lymphoblastoid cell lines infected with simian type D retrovirus Aids Research and Human Retroviruses. 7: 899-909. PMID 1662056 DOI: 10.1089/Aid.1991.7.899 |
0.335 |
|
| Show low-probability matches. |